Humana Inc. HUM entered into a multi-year tie-up with Montefiore, one of New York’s premier academic health systems, to provide its Medicare Advantage members with access to the health system’s in-network medical care.Effective Jul 1, 2021, the deal includes Montefiore Health System’s 10 hospitals, more than 200 outpatient sites, around 4,000 physicians and 5,450 nurses across the Bronx, Westchester and the Hudson Valley.The leading health insurer forged this partnership to widen the reach of top-notch healthcare facilities among its current and future members.Montefiore has 25 plus years to its creditin enhancing population health and this unique relationship is expected to help it cater to the growing Medicare population. Humana has a reputation for focusing on medical care of the communities it serves. It constantly collaborates with companies to improve overall health outcomes of people.Last month, Humana's arm CenterWell Senior Primary Care partaken in a new federal population health program, enabling the unit to boost its care-team medical facilities for Original Medicare beneficiaries.The leading health insurer’s Medicare business has been performing strongly from the past many years. This is evident from 54% Medicare membership growth from 2013 to 2020 sans 2019 when it was down by 1%.For the full year, the company expects individual Medicare Advantage membership growth of around 425,000-475,000 members, suggesting an 11-12% rise from the year-ago reported figure. This, in turn, is expected to contribute to revenue growth.Zacks Rank & Price PerformanceShares of this presently Zacks Rank #3 (Hold) healthcare provider have gained 19.3% in a year compared with the industry’s rally of 35.7%.Image Source: Zacks Investment ResearchStocks to ConsiderSome better-ranked stocks in the same space are Magellan Health, Inc. MGLN, Molina Healthcare, Inc. MOH and UnitedHealth Group Incorporated UNH, each holding a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Magellan Health, Molina Healthcare and UnitedHealth Group came up with a trailing four-quarter surprise of 69.6%, 17.7% and 20.21%, respectively, on average. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Humana Inc. (HUM): Free Stock Analysis Report Molina Healthcare, Inc (MOH): Free Stock Analysis Report Magellan Health, Inc. (MGLN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research